Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx

European Archives of Oto-Rhino-Laryngology

Volumn 263, Issue 1, 2006, Pages 43-48

  Rydzanicz, Malgorzata ^a   Golusinski, Pawel ^b   Mielcarek Kuchta, Daniela ^b   Golusinski, Wojciech ^b   Szyfter, Krzysztof ^a,b  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

CCND1 polymorphism; Cyclin D1; Larynx cancer; Lymph node metastases

Indexed keywords

CYCLIN D1;

ADULT; AGED; ALLELE; ARTICLE; BIOLOGY; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HETEROZYGOSITY; HUMAN; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; GENE FREQUENCY; GENES, BCL-1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 29344464892     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-005-0957-7     Document Type: Article

References (40)

1. Akervall A, Michalides R, Mineta H, Balm A, Borg A, Dictor M, Jin Y, Loftus B, Martens F, Wennerberg J (1997) Amplification of cyclin D1 in squamous cell carcinoma of he head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79:380-389
2. Akervall A, Borg A, Dictor M, Ji C, Jin Y, Tanner M, Isola J, Martens F, Wennerberg J (2002) Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Int J Oncol 20:45-52
3. Bartkova J, Lukas J, Bartek J (1997) Aberrations of the G1-and G1/S-regulating genes in human cancer. Prog Cell Cycle Res 3:211-220
4. Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, Scambia G, Neri G (1996) Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 2:175-180
5. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder W, Heighway J (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11:1005-1011
6. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG (1994) Prad-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74:152-158
7. de Boer CJ, Loyson S, Kluin PM, Kluion-Neleman HC, Schuuring E, van Krieken JH (1993) Multiple breakpoints with the bcl-1 locus in B-cell lymphoma: rearrangement of the cyclin D1 gene. Cancer Res 6:4148-4152
8. Diehl JA (2002) Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226-231
9. Diehl JA, Zindy F, Sherr CJ (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 11:957-972
10. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511
11. Donnellan R, Chetty R (1998) Cyclin D1 and human neoplasia (reviews). Mol Pathol 51:1-7
12. Dowdy S, Hinds P, Louie K, Reed S, Arnold A, Weinberg R (1992) Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-411
13. Gleich LL, Salamone FN (2002) Molecular genetics of head and neck cancer. Cancer Control 9:369-378
14. Holley SL, Parkes G, Matthias C, Bockmuhl U, Jahnke V, Leder K, Strange RC, Fryer AA, Hoban PR (2001) Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 159:1917-1924
15. Hosokawa Y, Tu T, Tahara H, Smith AP, Arnold A (1995) Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism. Cancer Lett 93:165-170
16. Izzo JG, Papadimitrakopoulou VA, Liu DD, den Hollander PL, Babenko IM, Keck J, El-Naggar AK, Shin DM, Lee JJ, Hong WK, Hittelman WN (2003) Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst 95:198-205
17. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Trassera J, Cardesa A (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54:4813-4817
18. Kong S, Wei Q, Amos CI (2001) Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 93:1106-1108
19. Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J, Jones PW, Strange RC, Fryer AA, Hoban P (1998) Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 4:2411-2418
20. Matthias C, Jahnke V, Jones PW, Hoban PR, Alldersea J, Worrall S, Anthony A, Fryer AA, Strange RC (1999) Cyclin D1, glutathione S-transferase and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomarkers 8:815-823
21. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of 47 operable squamous cell carcinomas of the head and neck. Cancer Res 55:975-978
22. Mielcarek-Kuchta D, Olofsson J, Golusinski W (2003) p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol 260:549-554
23. Morgan DO (1995) Principles of CDK regulation. Nature 374:131-134
24. Nishimoto IN, Pinheiro NA, Rogatto SR, Carvalho AL, Simpson AJ, Caballero OL, Kowalski LP (2004) Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol 40:604-610
25. Pignatora L, Pruneri G, Carboni N, Capaccio P, Cesana BM, Neri A, Buffa R (1998) Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 16:3069-3077
26. Porter TR, Richards FM, Houlston RS (2002) Contribution of cyclin D1(CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 21:1928-1933
27. Qiuling S, Yuxin Z, Suhua Z, Cheng X, Shuguang L, Fengsheng H (2003) Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis 24:1499-1503
28. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559-1571
29. Rogers S, Wells R, Rechsteiner M (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234:364-368
30. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, Hara M, Saito I (1998) Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16:1701-1712
31. Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene (Amst) 159:83-96
32. Schuuring E, Verhoeven E, Mooi WJ, Michalides R (1992) Identification and cloning of two overexpressed genes, U21B31/PRAD and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355-361
33. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Knudsen ES (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 8:30339-30347
34. Wang L, Habuchi T, Takahashi T (2002) Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23:257-264
35. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671
36. Wang X, Pavelic ZP, Li Y-Q, Wang L, Gleich L, Radack K, Gluckman JL, Stambrook PJ (1995) Amplification and overexpressio of cyclin D1 gene in head and neck squamous cell carcinoma. J Clin Pathol Mol Pathol 48:256-259
37. Williams ME, Gaffey M J, Weiss LM, Wilczynski SP, Schuuring E, Levine PA (1993) Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 119:1238-1243
38. Yu Q, Geng Y, Sicinski P (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature 28:1017-1021
39. Zheng Y, Shen H, Sturgis EM (2001) Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 22:1195-1199
40. Zhou P, Jiang W, Weghorst CM, Weinstein IB (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56:36-39